Richard G Vincent Oncternal Therapeutics, Inc. (ONCT) insider trading activity

Richard G Vincent is Chief Financial Officer of Oncternal Therapeutics, Inc.. Currently has a direct ownership of 140,922 shares of ONCT, which is worth approximately $159,241. The most recent transaction as insider was on Jan 03, 2024, when has been sold 8,868 shares (Common Stock) at a price of $0.5 per share, resulting in proceeds of $4,434. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 141K

0% 3M change

5.92% 12M change

Total Value Held $159,241

RICHARD G VINCENT Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 03 2024	SELL Payment of exercise price or tax liability	$4,434 $0.5 p/Share	8,868 Reduced 5.92%	140,922 Common Stock
Jul 03 2023	SELL Payment of exercise price or tax liability	$2,544 $0.36 p/Share	7,069 Reduced 4.51%	149,790 Common Stock
Apr 13 2023	BUY Open market or private purchase	$9,000 $0.3 p/Share	30,000 Added 16.05%	156,859 Common Stock
Jan 03 2023	SELL Payment of exercise price or tax liability	$4,516 $1.02 p/Share	4,428 Reduced 3.37%	126,859 Common Stock
Jul 28 2022	BUY Grant, award, or other acquisition	-	43,125 Added 24.73%	131,287 Common Stock
Mar 28 2022	BUY Open market or private purchase	$3,500 $1.4 p/Share	2,500 Added 2.76%	88,162 Common Stock
Mar 25 2022	BUY Open market or private purchase	$3,671 $1.47 p/Share	2,497 Added 2.83%	85,662 Common Stock
Mar 24 2022	BUY Open market or private purchase	$4 $1.45 p/Share	3 Added 0.0%	83,165 Common Stock
Jan 28 2022	BUY Open market or private purchase	$4,125 $1.65 p/Share	2,500 Added 2.92%	83,162 Common Stock
Jan 27 2022	BUY Open market or private purchase	$17,500 $1.75 p/Share	10,000 Added 11.03%	80,662 Common Stock
Jan 03 2022	BUY Grant, award, or other acquisition	-	29,867 Added 29.71%	70,662 Common Stock

Also insider at

FBRX

Forte Biosciences, Inc. Healthcare

RGV